Notice 21 Aug 2025 compliance, regulations, pharmaceutical, importation, controlled substances, drug enforcement

💊Vici Health Sciences' Import Application for Controlled Substances

Vici Health Sciences, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Aug 2025 regulatory compliance, pharmaceuticals, usa, controlled substances, drug enforcement, cambrex

💊Cambrex High Point Applies for Controlled Substances Manufacturing

Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Aug 2025 compliance, import regulations, controlled substances, drug enforcement, cambrex high point

📦Cambrex High Point's Application for Controlled Substances Import

Cambrex High Point, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Aug 2025 regulatory compliance, pharmaceutical industry, importation, controlled substances, drug enforcement

💊Catalent CTS, LLC DEA Importer Application Overview

Catalent CTS, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 21 Aug 2025 compliance, business regulation, pharmaceuticals, dea, controlled substances, drug enforcement

💊DEA Notice on Continuus Pharmaceuticals' Bulk Manufacturing Application

Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 20 Aug 2025 compliance, healthcare, dea, florida, drug enforcement, medical regulations

🚫DEA Revokes Registration for Physician Following License Suspension

The Drug Enforcement Administration has issued an Order to Show Cause for the revocation of Kenneth Pherson, D.O.'s registration, citing the suspension of his state medical license in Florida. This decision emphasizes the necessity for practitioners to maintain state authority to prescribe controlled substances, as federal compliance hinges on state licensure. The document details the procedural actions taken by the DEA and the implications of default by the registrant.

Learn More
Notice 12 Aug 2025 business registration, legal requirements, regulatory compliance, controlled substances, drug enforcement

💊Benuvia Operations LLC's Application for Controlled Substance Manufacturing

Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 business regulation, controlled substances, pharmaceuticals, compliance, drug enforcement, dea

💊DEA Notice

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 pharmaceutical industry, controlled substances, import regulations, compliance, drug enforcement

💊Chattem Chemicals Applies for Import of Controlled Substances

Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 11 Aug 2025 business compliance, controlled substances, healthcare, drug enforcement, clinical trials, dea, benuvia operations

💊Benuvia Operations LLC Applies for Controlled Substances Import Registration

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More